
Pfizer Says COVID-19 Vaccine Shows ‘100% Efficacy’ In Adolescents
By: Bill Chappell, NPR New clinical trials showed that Pfizer’s COVID-19 vaccine elicits “100% efficacy and robust antibody responses” in adolescents from 12 to 15 years
By: Bill Chappell, NPR New clinical trials showed that Pfizer’s COVID-19 vaccine elicits “100% efficacy and robust antibody responses” in adolescents from 12 to 15 years
UCLA Health’s Dr. Annabelle de St. Maurice explains the risk of such large gatherings despite increased vaccinations. Maskless spring break revelers traveling to Florida may
By: Bo Tefu, California Black Media Business and Labor leaders are joining hands with women working in male-dominated industries in California, stepping up their participation in
By: Dr. John E. Warren, Publisher San Diego Voice & Viewpoint Newspaper Nationwide — We understand that Mr. Johnson, as President of the National Association for the
By: LAURAN NEERGAARD, Associated Press So far in the U.S., teen testing is furthest along: Pfizer and Moderna expect to release results soon showing how
Inland Valley News is a proud member of National Publishers Association (NNPA), The Charter News, New American Media (NAM), The California Black Media Association (CBMA), Southern California Black Chamber of Commerce and Orange County Black Chamber of Commerce